Overall (n=83) | Group 1 (n=35) | Group 2 (n=17) | Group 3 (n=31) | P value | |
Age | 38.1±15.9 | 37.03±16 | 34.5±13.6 | 41.2±16.9 | 0.35* |
0.32† | |||||
Female sex (n,%) | 28 (33.7%) | 13 (37.1%) | 4 (23.5) | 11 (35.5) | 0.35* |
0.98† | |||||
WBC (103/μL) | 14.2±4.9 | 13.3±3.4 | 13.8±5.1 | 15.2±5.3 | 0.36* |
0.28† | |||||
Neutrophil (103 /µL) count | 11.5±4.9 | 10.4±3.4 | 10.9±4.9 | 12.8±5.6 | 0.2* |
0.17† | |||||
Lymphocyte (103 /µL) count | 1.6±0.7 | 1.8±0.8 | 1.6±0.7 | 1.4±0.8 | 0.2* |
0.32† | |||||
NLR | 10.9±12.7 | 7.5±5.9 | 10.4±13.9 | 13.5±13.9 | 0.3* |
0.38† | |||||
ESR | 40.4±19.4 | 30.5±11.4 | 40.7±13.5 | 51.2±23.4 | <0.01* |
<0.01† | |||||
CRP (mg/L) | 148.1±116.2 | 105.6±83.1 | 126.4±95.8 | 199.5±128.2 | <0.01* |
0.012† |
*Between all study groups.
†Group 1 versus group 2.
CRP, C reactive protein; ESR, erythrocyte sedimentation rate; NLR, neutrophil-to-lymphocyte ratio; WBC, white blood cell.